Freestone Grove Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136M Buy
554,373
+407,303
+277% +$94.9M 0.96% 4
2025
Q4
$30.4M Buy
147,070
+141,687
+2,632% +$28M 0.22% 152
2025
Q3
$998K Buy
+5,383
New +$922K 0.01% 440
2025
Q1
Sell
-14,813
Closed -$2.14M 693
2024
Q4
$2.14M Buy
+14,813
New +$2.3M 0.03% 261

Other funds holding JNJ

Freestone Grove Partners's JNJ Position: Q1 2026 in Review

Freestone Grove Partners increased its Johnson & Johnson (JNJ) stake by 277% in Q1 2026, buying an estimated $94.9M and bringing the position to 554,373 shares worth $136M. The position accounts for 0.96% of the portfolio, ranked #4.

Freestone Grove Partners first reported a position in JNJ in Q4 2024 and has held it in 4 quarters since. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Freestone Grove Partners held 554,373 shares of Johnson & Johnson worth $136M as of Q1 2026.
  • Freestone Grove Partners bought 407,303 Johnson & Johnson shares in Q1 2026, an estimated $94.9M.
  • Johnson & Johnson made up 0.96% of Freestone Grove Partners's portfolio in Q1 2026, its #4 holding.
  • Freestone Grove Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 4 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.